Effect of methylnaltrexone and naloxone on esophageal motor function in man. Issue 3 (22nd January 2017)

• Record Type: Journal Article
• Authors: Scarpellini, E.; Pauwels, A.; Vos, R.; Rommel, N.; Tack, J.
• Is Part Of: Neurogastroenterology & motility. Volume 29:Issue 3(2017)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2017-01-22
• Subjects: GERD -- methylnaltrexone -- naloxone -- TLESRs -- μ‐opioid receptors; Gastrointestinal system -- Motility -- Periodicals; Gastrointestinal system -- Innervation -- Periodicals; 616.33
• DOI: 10.1111/nmo.12938
• Languages: English
• ISSNs: 1350-1925

Abstract

Abstract: Background: Endogenous opioids (EO) acting on μ‐opiod receptors in central and enteric nervous system (ENS) control gastrointestinal motility but it is still unclear whether EO in ENS may control esophageal function in man, thus we will study the effects of methylnaltrexone (MNTX), a peripherally selective, and naloxone (NA), a non‐selective μ‐opiod receptor antagonist, on esophageal motility in healthy subjects. Methods: Fifteen HV (6 M; 34.1 ± 0.6 years; BMI: 22.1 ± 0.1 kg/m 2 ) underwent three esophageal high‐resolution manometry impedance (HRiM) studies with 10 saline swallows administered every 30 minutes: drug was administered after 30 minutes (MNTX subcutaneously/NA or saline intravenously), a solid meal after 90 minutes; measurements continued for 120 minutes postprandially. Key Results: Methylnaltrexone did not significantly decrease the upper esophageal sphincter (UES) percentage of relaxation preprandially (72.5 ± 5 vs 66.9 ± 4.6 and 73 ± 3.8%, ANOVA between placebo, MNTX and NA, P =NS) and postprandially (60 minutes: 68.2 ± 5.6 vs 61 ± 5.5 and 67.1 ± 5.6%; 120 minutes: 68 ± 5.9 vs 59.3 ± 5.2 and 67.7 ± 4.7%; ANOVA between placebo, MNTX and NA, P =NS). MNTX and NA did not significantly alter preprandial and postprandial LES resting pressures and integrated relaxation pressure (ANOVA between placebo, MNTX and NA, all P =NS). Peak front velocity and distal contractile integral were not altered pre‐ and postprandially by MNTX and NA (ANOVA between placebo, MNTX and NA, P =NS). Transient lower esophageal sphincter relaxations (TLESRs') number was not altered by MNTX and NA (ANOVA between placebo, MNTX and NA, all P =NS). Conclusions and Inferences: The peripheral selective and non‐selective μ‐opioid receptor antagonists MNTX and NA, respectively, do not alter TLESRs occurrence and esophageal peristalsis. Abstract : Influence of methylnaltrexone and naloxone on upper esophageal sphincter resting pressure and relaxation.